375 related articles for article (PubMed ID: 34788243)
41. Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension.
Heckmann JG; Faschingbauer F; Lang C; Reulbach U; Dütsch M; Mardin CY; Schwab S
J Neurosurg; 2007 Sep; 107(3):543-7. PubMed ID: 17886553
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the patients diagnosed as idiopathic intracranial hypertension with and without papilledema visual pathways by analysis of visual evoked potential.
Kisabay A; Selcuki D; Zeybek S; Batum M
Int J Neurosci; 2021 Feb; 131(2):183-190. PubMed ID: 32125204
[TBL] [Abstract][Full Text] [Related]
43. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
[TBL] [Abstract][Full Text] [Related]
44. Undiagnosed papilledema in a morbidly obese patient population: a prospective study.
Krispel CM; Keltner JL; Smith W; Chu DG; Ali MR
J Neuroophthalmol; 2011 Dec; 31(4):310-5. PubMed ID: 21799447
[TBL] [Abstract][Full Text] [Related]
45. Thinning of the Skull Base and Calvarial Thickness in Patients With Idiopathic Intracranial Hypertension.
Barke M; Castro HM; Adesina OO; Chuang AZ; Do T; Patel RP; Richani K
J Neuroophthalmol; 2022 Jun; 42(2):192-198. PubMed ID: 35195543
[TBL] [Abstract][Full Text] [Related]
46. Case Report: Cerebrospinal Fluid Dynamics in the Optic Nerve Subarachnoid Space and the Brain Applying Diffusion Weighted MRI in Patients With Idiopathic Intracranial Hypertension-A Pilot Study.
Berberat J; Pircher A; Gruber P; Lovblad KO; Remonda L; Killer HE
Front Neurol; 2022; 13():862808. PubMed ID: 35493818
[TBL] [Abstract][Full Text] [Related]
47. Lumbar Puncture for Diagnosis of Idiopathic Intracranial Hypertension in Typical Patients.
Margolis MS; DeBusk AA; Moster ML; Falardeau JM; Eggenberger ER; Sergott RC; Van Stavern GP
J Neuroophthalmol; 2021 Sep; 41(3):375-378. PubMed ID: 34369470
[TBL] [Abstract][Full Text] [Related]
48. External lumbar drainage in progressive pediatric idiopathic intracranial hypertension.
Dotan G; Hadar Cohen N; Qureshi HM; Shapira Rootman M; Nevo Y; Kershenovich A
J Neurosurg Pediatr; 2021 Jul; 28(4):490-496. PubMed ID: 34271543
[TBL] [Abstract][Full Text] [Related]
49. Clinical and demographic differences between idiopathic intracranial hypertension patients with mild and severe papilledema.
Micieli JA; Gorham JP; Bruce BB; Newman NJ; Biousse V; Peragallo JH
Taiwan J Ophthalmol; 2021; 11(1):53-56. PubMed ID: 33767955
[TBL] [Abstract][Full Text] [Related]
50. Etiology of Papilledema in Patients in the Eye Clinic Setting.
Crum OM; Kilgore KP; Sharma R; Lee MS; Spiegel MR; McClelland CM; Bhatti MT; Chen JJ
JAMA Netw Open; 2020 Jun; 3(6):e206625. PubMed ID: 32484553
[TBL] [Abstract][Full Text] [Related]
51. Pseudotumor cerebri in children with Down syndrome.
Esmaili N; Bradfield YS
Ophthalmology; 2007 Sep; 114(9):1773-8. PubMed ID: 17368546
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension.
Eren Y; Kabatas N; Guven H; Comoglu S; Gurdal C
Acta Neurol Belg; 2019 Sep; 119(3):351-357. PubMed ID: 30120685
[TBL] [Abstract][Full Text] [Related]
53. Concomitant optic disk drusen and papilledema due to idiopathic intracranial hypertension in a pediatric cohort.
Tavakoli M; Yan F; Tauscher R
J AAPOS; 2024 Feb; 28(1):103806. PubMed ID: 38216114
[TBL] [Abstract][Full Text] [Related]
54. Pseudopapilledema and association with idiopathic intracranial hypertension.
Liu B; Murphy RK; Mercer D; Tychsen L; Smyth MD
Childs Nerv Syst; 2014 Jul; 30(7):1197-200. PubMed ID: 24573961
[TBL] [Abstract][Full Text] [Related]
55. Anterior lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma.
Villarruel JM; Li XQ; Bach-Holm D; Hamann S
Eur J Ophthalmol; 2017 Jan; 27(1):55-61. PubMed ID: 27198638
[TBL] [Abstract][Full Text] [Related]
56. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
[TBL] [Abstract][Full Text] [Related]
57. Non-invasive Measurement of the Viscoelasticity of the Optic Nerve and Sclera for Assessing Papilledema: A Pilot Clinical Study.
Bui NT; Kazemi A; Sit AJ; Larson NB; Greenleaf J; Chen JJ; Zhang X
Ultrasound Med Biol; 2023 Oct; 49(10):2227-2233. PubMed ID: 37517885
[TBL] [Abstract][Full Text] [Related]
58. Seizure as the presenting sign of idiopathic intracranial hypertension.
Sayal AP; Vyas M; Micieli JA
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35039363
[TBL] [Abstract][Full Text] [Related]
59. Comparison of Idiopathic Intracranial Hypertension Patients With and Without Anemia.
Sverdlichenko I; Yu CW; Margolin E; Micieli JA
J Neuroophthalmol; 2023 Dec; 43(4):535-540. PubMed ID: 36255106
[TBL] [Abstract][Full Text] [Related]
60. Transorbital sonography and MRI reliability to assess optic nerve sheath diameter in idiopathic intracranial hypertension.
Roemer SN; Friedrich EB; Kettner M; Rauzi M; Schub P; Kulikovski J; Janitschke D; Stögbauer J; Lochner P
J Neuroimaging; 2023; 33(3):375-380. PubMed ID: 36859645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
